We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

66 hedge funds and large institutions have $96.4M invested in Aldeyra Therapeutics in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,300% more call options, than puts

Call options by funds: $42K | Put options by funds: $3K

420% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 5

320% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 5

47% more funds holding

Funds holding: 45 → 66 (+21)

25% more capital invested

Capital invested by funds: $77.1M → $96.4M (+$19.3M)

6.53% more ownership

Funds ownership: 53.79% → 60.33% (+6.5%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
66
Holders Change
+21
Holders Change %
+46.67%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
21
Reduced
5
Closed
5
Calls
$42K
Puts
$3K
Net Calls
+$39K
Net Calls Change
-$338K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.91M
2
State Street
State Street
Massachusetts
+$1.68M
3
KC
Kepos Capital
New York
+$1.51M
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.34M
5
Northern Trust
Northern Trust
Illinois
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.29M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$331K
3
Millennium Management
Millennium Management
New York
-$225K
4
ECM
Element Capital Management
New York
-$123K
5
Goldman Sachs
Goldman Sachs
New York
-$117K
Name Holding Trade Value Shares
Change 		Change in
Stake
EIM
26
Essex Investment Management
Massachusetts
$312K +$313K +39,215 New
FPC
27
Falcon Point Capital
California
$270K +$271K +33,969 New
Deutsche Bank
28
Deutsche Bank
Germany
$243K +$244K +30,556 New
Charles Schwab
29
Charles Schwab
California
$237K +$237K +29,700 New
OAM
30
Oxford Asset Management
United Kingdom
$207K +$205K +25,655 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$194K +$194K +24,369 New
TCIM
32
TIAA CREF Investment Management
New York
$194K +$195K +24,422 New
Renaissance Technologies
33
Renaissance Technologies
New York
$184K -$59.8K -7,500 -25%
PCM
34
Prelude Capital Management
New York
$170K +$149K +18,684 +684%
HighTower Advisors
35
HighTower Advisors
Illinois
$154K – – –
TA
36
Teachers Advisors
New York
$154K +$155K +19,428 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$140K +$140K +17,600 New
DS
38
DRW Securities
Illinois
$135K +$39.9K +5,000 +42%
Wells Fargo
39
Wells Fargo
California
$133K +$18.4K +2,307 +16%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$113K +$114K +14,256 New
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$110K +$47.2K +5,915 +75%
VF
42
Virtu Financial
New York
$104K +$104K +13,068 New
Citadel Advisors
43
Citadel Advisors
Florida
$91K +$1.27K +159 +1%
Stifel Financial
44
Stifel Financial
Missouri
$85K +$1.2K +150 +1%
AG
45
Algert Global
California
$83K +$83.2K +10,424 New
AIG
46
American International Group
New York
$82K +$82.8K +10,373 New
FIA
47
FNY Investment Advisers
New York
$79K +$79.8K +10,000 New
UBS Group
48
UBS Group
Switzerland
$57K +$5.7K +715 +11%
SO
49
STRS Ohio
Ohio
$37K +$37.5K +4,700 New
Bank of America
50
Bank of America
North Carolina
$24K -$12.1K -1,517 -33%
1
2
3

ALDX Hedge Fund Activity: Q2 2018 in Review

66 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2018, worth a combined $96.4M — up 25% from $77.1M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ALDX positions and 5 closed out — a net gain of 21 holders — while 21 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $5.91M. The largest seller was Sphera Funds Management, cutting an estimated $1.29M.

  • 66 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2018, up from 45 in Q1 2018.
  • Funds reported $96.4M of Aldeyra Therapeutics stock for Q2 2018, up 25% quarter-over-quarter.
  • 26 funds opened new Aldeyra Therapeutics positions in Q2 2018 and 5 closed out, a net change of +21 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2018 was BlackRock, an estimated $5.91M added.
  • The largest Aldeyra Therapeutics seller in Q2 2018 was Sphera Funds Management, an estimated $1.29M sold.

Based on aggregated 13F filings for Q2 2018.